|
Quotes & Info
|
| DNR > SEC Filings for DNR > Form 8-K on 5-Nov-2009 | All Recent SEC Filings |
5-Nov-2009
Entry into a Material Definitive Agreement
On November 1, 2009, Denbury Resources Inc. (NYSE: DNR) ("Denbury") and
Encore Acquisition Company (NYSE: EAC) ("Encore") announced that they had
entered into a definitive merger agreement pursuant to which Denbury will
acquire Encore in a stock and cash transaction valued at approximately
$4.5 billion, including the assumption of debt and the value of the minority
interest in Encore Energy Partners LP (NYSE: ENP) ("Encore MLP"). The combined
company will continue to be known as Denbury Resources Inc. (the "Company") and
will be headquartered in Plano, Texas.
The Agreement and Plan of Merger by and between Denbury and Encore dated
October 31, 2009 (the "Merger Agreement") was unanimously approved by the boards
of directors of both Denbury and Encore. The Merger Agreement contemplates a
merger (the "Merger") whereby Encore will be merged with and into Denbury, with
Denbury surviving the Merger. The Merger is subject to the stockholders of each
of Denbury and Encore approving the Merger, including approval by Denbury's
stockholders of the issuance of Denbury common stock to be used as Merger
consideration.
Under the agreement, Encore stockholders will receive $50.00 per share for
each share of Encore common stock, comprised of $15.00 in cash and $35.00 in
Denbury common stock subject to both an election feature and a collar mechanism
on the stock portion of the consideration as set forth in more detail below.
Merger Agreement
Exchange Ratio
In calculating the exchange ratio range for the collar mechanism, the Denbury
common stock was initially valued at $15.10 per share. The collar mechanism is
limited to a 12% upward or downward movement in the Denbury share price. The
final number of Denbury shares to be issued will be adjusted based on the volume
weighted average price of Denbury common stock on the NYSE for the 20 day
trading period ending on the second day prior to closing. Based on this
mechanism, if Denbury stock trades between $13.29 and $16.91, the Encore
stockholders will receive between 2.0698 and 2.6336 shares of Denbury common
stock for each of their shares of Encore common stock, but not higher or lower
than these share amounts if Denbury common stock trades outside this range. If
Denbury common stock trades outside of this range, the value of the shares of
Denbury received will represent either more or less than $35 per share.
Encore stockholders will also have an option to elect to receive all stock or
all cash, subject to a proration feature, such that if Denbury stock trades
within this range, the overall mix of consideration will be 70% Denbury common
stock and 30% cash in the aggregate. Subject to proration, Encore stockholders
electing to receive all cash will receive $50 per share in cash, and Encore
stockholders electing to receive only Denbury common stock will receive for each
Encore share between 2.9568 and 3.7622 shares of Denbury common stock. In
addition, upon completion of the Merger, all Encore stock options will fully
vest and their value will be paid in cash. All Encore restricted stock will vest
and each holder will have the opportunity to make the same elections as other
holders of Encore common stock as described above, except for shares of Encore
restricted stock granted as a 2009 bonus pursuant to the Encore annual incentive
program, which will be converted into restricted shares of Denbury common stock.
Representations and Warranties
The Merger Agreement has been included to provide security holders with
information regarding its terms. It is not intended to provide factual
information about Encore or Denbury. The Merger Agreement contains
representations and warranties of Denbury and Encore made to each other as of
specific dates, which should not be relied on by any other person or entity for
any purpose. The assertions embodied in those representations and warranties
were made solely for purposes of the contract between Denbury and Encore and may
be subject to important qualifications and limitations agreed to by Denbury and
Encore in connection with the negotiated terms, which qualifications and
limitations are not necessarily reflected in the Merger Agreement. Moreover,
some of those representations and warranties may not be accurate or complete as
of any specified date, may be subject to a contractual standard of materiality
different from those generally applicable to stockholders or may have been used
for purposes of allocating risk between Denbury and Encore rather than
establishing matters as fact.
Covenants
The Merger Agreement contains customary covenants by each party to the Merger
Agreement. Such covenants include, among others, covenants that both Denbury and
Encore will operate their respective businesses in the ordinary course and in a
manner consistent with past practices, subject to limited exceptions, and
covenants by both Denbury and Encore that their respective boards of directors
not change their recommendations to the stockholders of each of them to vote in
favor of the Merger, subject to exceptions specified in the Merger Agreement.
Encore has also agreed not to solicit or initiate discussions with third parties
regarding other proposals to acquire Encore and to certain restrictions on its
ability to respond to any such proposal.
Conditions to Closing
Consummation of the Merger is subject to customary conditions, including,
among others, (a) the approval of the stockholders of each of Denbury and
Encore, (b) the absence of any material adverse effect, (c) the expiration or
early termination of the applicable Hart-Scott-Rodino Act waiting period,
(d) the absence of any order or injunction prohibiting the consummation of the
Merger, (e) the effectiveness of the registration statement of Denbury filed on
Form S-4, (f) the approval of the listing of the shares of Denbury common stock
to be issued in the Merger on the New York Stock Exchange, (g) the accuracy of
the parties' respective representations and warranties as set forth in the
Merger Agreement, subject, as to certain of the representations and warranties
as specified in the Merger Agreement, to materiality, (h) the receipt of legal
opinions stating, among other things, that the Merger will constitute a
reorganization under Section 368(a) of the Internal Revenue Code of 1986, as
amended, (i) the receipt of all approvals or reviews required by federal and
state regulatory authorities and (j) financing.
In connection with the Merger Agreement, Denbury received a commitment letter
from J.P. Morgan Securities Inc. and JPMorgan Chase Bank, N.A., subject to
certain funding conditions, for a proposed new $1.6 billion senior secured
revolving credit facility with a term of four years and a $1.25 billion bridge
facility that will be available to the extent Denbury does not secure alternate
financing prior to the end of the bridge takedown period. The bridge facility,
if drawn,
will initially mature on the first anniversary of the closing of the Merger, at
which time the maturity of any outstanding loans thereunder will be
automatically extended to the seventh anniversary of the closing of the Merger,
except to the extent they have been previously exchanged by the lender for
exchange notes due on such seventh anniversary. The new debt financing will be
used to pay the cash consideration in the Merger, repay amounts outstanding
under Denbury's current $900 million revolving credit facility and potentially
retire and replace $825 million of Encore's outstanding subordinated notes, all
of which have a change of control put option at 101%, replace Encore's existing
bank facility which has approximately $180 million currently drawn and
outstanding, and for other fees and expenses. Denbury has also received a
commitment from J. P. Morgan Securities Inc. and JP Morgan Chase Bank to fund a
new $375 million senior secured revolving credit facility to replace an existing
Encore MLP revolving loan facility should Denbury and Encore be unable to obtain
a waiver of covenants and amendment to such loan facility to allow for the
Merger. Fee letters executed in connection with the bank commitment letter
provide for Denbury to pay up to approximately $50 million in fees if the loans
do not close.
Termination
The Merger Agreement contains certain termination rights for both Denbury and
Encore, including, among others, if the Merger is not completed by May 31, 2010.
In the event of a termination of the Merger Agreement under certain
circumstances, Encore may be required to pay Denbury a termination fee of either
$60 million or $120 million, or Denbury may be required to pay Encore a
termination fee of either $60 million, $120 million or $300 million, in each
case depending on the circumstances of the termination. In addition, Encore is
obligated to reimburse Denbury for up to $10 million of its expenses related to
the Merger if specified termination events occur.
The foregoing description of the Merger Agreement does not purport to be
complete and is qualified in its entirety by reference to the full text of the
Merger Agreement, which is filed as Exhibit 2.1 hereto and is incorporated by
reference herein.
Additional Information
In connection with the transaction, Denbury and Encore will file a joint
proxy statement/prospectus and other documents with the Securities and Exchange
Commission. Investors and security holders are urged to carefully read the
definitive joint proxy statement/prospectus when it becomes available because it
will contain important information regarding Denbury, Encore and the
transaction.
A definitive joint proxy statement/prospectus will be sent to stockholders of
Denbury and Encore seeking their approval of the transaction. Investors and
security holders may obtain a free copy of the definitive joint proxy
statement/prospectus (when available) and other documents filed by Denbury and
Encore with the SEC at the SEC's website at www.sec.gov. The definitive joint
proxy statement/prospectus (when available) and such other documents relating to
Denbury may also be obtained free-of-charge by directing a request to Denbury,
Attn: Investor Relations, 5100 Tennyson Parkway, Suite 1200, Plano, Texas 75024
or from Denbury's website, www.denbury.com. The definitive joint proxy
statement/prospectus (when available) and such other documents relating to
Encore may also be obtained free-of-charge by directing a request to Encore,
Attn: Investor Relations, 777 Main Street, Suite 1400, Fort Worth, Texas 76102,
or from Encore's website, www.encoreacq.com.
Participants in Solicitation
Denbury, Encore and their respective directors and executive officers may,
under the rules of the SEC, be deemed to be "participants" in the solicitation
of proxies in connection with the proposed transaction. Information concerning
the interests of the persons who may be "participants" in the solicitation will
be set forth in the joint proxy statement/prospectus when it becomes available.
Forward-Looking Statements
This report contains "forward-looking statements" that involve significant
risks and uncertainties. All statements other than statements of historical fact
are statements that could be deemed forward-looking statements, including:
statements regarding the anticipated timing of filings and approvals relating to
the Merger; statements regarding the expected timing of the completion of the
Merger; statements regarding the ability to complete the Merger considering the
various closing conditions; any statements of expectation or belief; and any
statements of assumptions underlying any of the foregoing. Investors and
security holders are cautioned not to place undue reliance on these
forward-looking statements. Actual results could differ materially from those
currently anticipated due to a number of risks and uncertainties. Risks and
uncertainties that could cause results to differ from expectations include: the
possibility that one or more closing conditions for the Merger may not be
satisfied or waived, including the failure to obtain the requisite approval of
either Denbury's or Encore's stockholders, the failure of Denbury to obtain the
requisite financing to fund the cash portion of the Merger consideration or the
possibility that a governmental entity may prohibit, delay or refuse to grant
approval for the consummation of the Merger; the effects of disruption from the
Merger making it more difficult to maintain relationships with employees,
business partners or governmental entities; other business effects, including
the effects of industry, economic or political conditions outside of the control
of Denbury or Encore; and other risks and uncertainties discussed in documents
filed with the Securities and Exchange Commission by Encore.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
2.1 Agreement and Plan of Merger, dated October 31, 2009, by and between
Denbury Resources Inc. and Encore Acquisition Company.
|
|